COST-EFFECTIVENESS ANALYSIS OF DEXLANSOPRAZOLE FOR THE TREATMENT OF EROSIVE ESOPHAGITIS COMPARED TO CONVENTIONAL PROTON PUMP INHIBITORS

被引:0
|
作者
Valencia-Romero, A. [1 ]
Gay-Molina, J. G. [2 ]
Chiu-Ugalde, J. [3 ]
Figueroa-Rodriguez, A. [3 ]
Lopez-Alvarenga, J. C. [4 ]
Sanchez-Kobashi, R. [2 ]
Vargas, J. A. [3 ]
机构
[1] Hosp Alta Especialidad PEMEX S, Mexico City, DF, Mexico
[2] Tecnol & Informat Salud SA CV, Mexico City, DF, Mexico
[3] Nycomed, Naucalpan, Edo Mexico, Mexico
[4] Hosp Gen Mexico OD, Mexico City, DF, Mexico
关键词
D O I
10.1016/j.jval.2012.08.771
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A329 / A329
页数:1
相关论文
共 50 条
  • [21] The cost-effectiveness of proton pump inhibitors for bleeding peptic ulcers: The unanswered questions
    Devlin, JW
    Welage, LS
    CRITICAL CARE MEDICINE, 2004, 32 (06) : 1415 - 1416
  • [22] Cost-Effectiveness of Chemoprevention With and Without Proton Pump Inhibitors in Barrett's Esophagus
    Sharaiha, Reem Z.
    Wang, Y. Claire
    Neugut, Alfred I.
    Abrams, Julian A.
    GASTROENTEROLOGY, 2011, 140 (05) : S204 - S205
  • [23] Cost-effectiveness of intravenous proton pump inhibitors in high-risk bleeders
    van Zanten, SV
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 18 (12): : 749 - 750
  • [24] COST-EFFECTIVENESS ANALYSIS OF CURRENT TREATMENT OPTIONS FOR EOSINOPHILIC ESOPHAGITIS
    Hiramoto, Brent
    Muftah, Mayssan
    Flanagan, Ryan
    Shah, Eric D.
    Chan, Walter W.
    GASTROENTEROLOGY, 2023, 164 (06) : S348 - S348
  • [25] Cost-Effectiveness Analysis of Current Treatment Options for Eosinophilic Esophagitis
    Hiramoto, Brent
    Muftah, Mayssan
    Flanagan, Ryan
    Shah, Eric D.
    Chan, Walter W.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2025, 120 (01): : 161 - 172
  • [26] Network Meta-analysis Comparing Vonoprazan and Proton Pump Inhibitors for Heartburn Symptoms in Erosive Esophagitis
    Oshima, Tadayuki
    Igarashi, Ataru
    Nakano, Hiroya
    Deguchi, Hisato
    Fujimori, Ikuo
    Fernandez, Jovelle
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2022, 56 (06) : 493 - 504
  • [27] Comparative effectiveness and acceptability of the FDA-licensed proton pump inhibitors for erosive esophagitis A PRISMA-compliant network meta-analysis
    Li, Mei-Juan
    Li, Qing
    Sun, Min
    Liu, Li-Qin
    MEDICINE, 2017, 96 (39)
  • [28] Pharmacoeconomic analysis of proton pump inhibitors on C & D esophagitis treatment in Spain
    Cordero, L.
    Jimenez, J.
    Hernandez, R.
    Coll, E.
    VALUE IN HEALTH, 2007, 10 (06) : A353 - A353
  • [29] Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding
    Leontiadis, GI
    Sreedharan, A.
    Dorward, S.
    Barton, P.
    Delaney, B.
    Howden, C. W.
    Orhewere, M.
    Gisbert, J.
    Sharma, V. K.
    Rostom, A.
    Moayyedi, P.
    Forman, D.
    HEALTH TECHNOLOGY ASSESSMENT, 2007, 11 (51) : 1 - +
  • [30] Esomeprazole versus other proton pump inhibitors in erosive esophagitis: A meta-analysis of randomized clinical trials
    Gralnek, Ian M.
    Dulai, Gareth S.
    Fennerty, M. Brian
    Spiegel, Brennan M. R.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (12) : 1452 - 1458